Jill Kolesar Selected Research

1,24-dihydroxyvitamin D2

12/2015

A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jill Kolesar Research Topics

Disease

32	Neoplasms (Cancer) 03/2022 - 11/2004
11	Prostatic Neoplasms (Prostate Cancer) 07/2020 - 09/2005
6	Nausea 06/2017 - 01/2002
4	Ovarian Neoplasms (Ovarian Cancer) 04/2022 - 03/2010
4	Fatigue 07/2016 - 01/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2006
3	Neoplasm Metastasis (Metastasis) 11/2019 - 11/2005
3	Vomiting 06/2017 - 01/2002
3	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2008
3	Disease Progression 11/2015 - 10/2009
3	Multiple Myeloma 05/2012 - 07/2008
3	Renal Cell Carcinoma (Grawitz Tumor) 12/2011 - 11/2004
2	Neuroendocrine Carcinoma 02/2022 - 11/2019
2	Carcinogenesis 01/2021 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 07/2008
2	Thrombocytopenia (Thrombopenia) 01/2021 - 07/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 05/2017 - 04/2012
2	Pain (Aches) 04/2017 - 01/2017
2	Neuroblastoma 04/2017 - 12/2010
2	Diarrhea 07/2016 - 11/2004
2	Colorectal Neoplasms (Colorectal Cancer) 05/2012 - 01/2002
2	Adenocarcinoma 05/2011 - 08/2008
2	Neutropenia 07/2008 - 05/2008
1	Cerebellar Ataxia (Dysmetria) 04/2022
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 04/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Circulating Neoplastic Cells 03/2019
1	Carcinoma (Carcinomatosis) 03/2018
1	Infections 01/2018
1	Cytopenia 01/2018
1	Fever (Fevers) 04/2017
1	Neuralgia (Stump Neuralgia) 04/2017
1	Hypokalemia 01/2017
1	Hot Flashes 01/2017
1	Myalgia 01/2017

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 02/2022 - 04/2012
6	Pharmaceutical PreparationsIBA 03/2022 - 07/2008
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2006
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2006
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2006
3	PlatinumIBA 01/2021 - 11/2015
3	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2015
3	Docetaxel (Taxotere)FDA Link 01/2018 - 10/2009
3	Biological ProductsIBA 05/2017 - 02/2013
3	Hormones (Hormone)IBA 01/2017 - 09/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 10/2009
3	Vitamin D FDA LinkGeneric 01/2016 - 06/2013
3	Bortezomib (Velcade)FDA Link 05/2012 - 07/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2010 - 05/2008
2	EnzymesIBA 01/2022 - 07/2020
2	ElectrolytesIBA 01/2018 - 04/2017
2	Monoclonal AntibodiesIBA 04/2017 - 11/2005
2	AndrogensIBA 01/2017 - 02/2013
2	Androgen Receptors (Androgen Receptor)IBA 01/2017 - 02/2013
2	GenisteinIBA 01/2016 - 04/2012
2	Capecitabine (Xeloda)FDA Link 02/2015 - 05/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 05/2012 - 11/2004
2	perifosineIBA 05/2012 - 11/2004
2	3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA 02/2011 - 08/2008
2	Carboplatin (JM8)FDA LinkGeneric 03/2010 - 05/2008
2	Antineoplastic Agents (Antineoplastics)IBA 10/2009 - 07/2008
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2009 - 08/2008
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 04/2022
1	Ataxin-7IBA 04/2022
1	polyglutamineIBA 04/2022
1	ivosidenibIBA 03/2022
1	big gastrinIBA 02/2022
1	Plicamycin FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Sp1 Transcription FactorIBA 01/2021
1	ormeloxifeneIBA 01/2021
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2021
1	navitoclaxIBA 01/2021
1	osimertinibIBA 01/2021
1	Lysine (L-Lysine)FDA Link 07/2020
1	Histone DemethylasesIBA 07/2020
1	Circulating Tumor DNAIBA 03/2019
1	Olanzapine (Zyprexa)FDA Link 06/2017
1	polyphenon EIBA 05/2017
1	TeaIBA 05/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 05/2017
1	PolyphenolsIBA 05/2017
1	dinutuximabIBA 04/2017
1	Isotretinoin (Accutane)FDA LinkGeneric 04/2017
1	Complement System Proteins (Complement)IBA 04/2017
1	AntigensIBA 04/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2017
1	Interleukin-2 (IL2)IBA 04/2017
1	Estrogens (Estrogen)FDA Link 01/2017
1	orteronelIBA 01/2017
1	Axitinib (AG 013736)IBA 12/2016

Therapy/Procedure

20	Therapeutics 04/2022 - 01/2002
8	Drug Therapy (Chemotherapy) 11/2019 - 05/2008
4	Chemoprevention 04/2016 - 04/2012
3	Precision Medicine 10/2020 - 12/2016
3	Immunotherapy 04/2017 - 12/2010
3	Prostatectomy (Retropubic Prostatectomy) 01/2016 - 06/2013
1	Transurethral Resection of Bladder 05/2017
1	Cystectomy 05/2017